These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4940610)

  • 1. Observations on the range of efficacy of L-dopa.
    Klawans HL
    Confin Neurol; 1971; 33(3):133-45. PubMed ID: 4940610
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on the efficacy of L-dopa in progressive supranuclear palsy.
    Klawans HL; Ringel SP
    Eur Neurol; 1971; 5(2):115-29. PubMed ID: 5117103
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progressive extra-pyramidal disorder in 2 young brothers. Remarkable effects of treatment with L-dopa].
    Castaigne P; Rondot P; Ribadeau-Dumas JL; Saïd G
    Rev Neurol (Paris); 1971 Feb; 124(2):162-6. PubMed ID: 5564861
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic modification of some neurologic disorders.
    Cotzias GC
    JAMA; 1969 Nov; 210(7):1255-62. PubMed ID: 5394649
    [No Abstract]   [Full Text] [Related]  

  • 5. L-dopa for progressive supranuclear palsy.
    Klawans HL
    Lancet; 1969 Dec; 2(7634):1359. PubMed ID: 4188117
    [No Abstract]   [Full Text] [Related]  

  • 6. [L-Dopa in the management of chronic manganese poisoning].
    Mena I; Court J; Fuenzalida S; Papavasiliou PS; Cotzias GC
    Rev Med Chil; 1969 Jun; 97(6):343-51. PubMed ID: 5379305
    [No Abstract]   [Full Text] [Related]  

  • 7. Parkinsonism-dementia of Guam: treatment with L-dopa.
    Schnur JA; Chase TN; Brody JA
    Neurology; 1971 Dec; 21(12):1236-42. PubMed ID: 4257247
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences in the treatment of Parkinsonism with L-dopa. IV. Effects on the experimental extrapyranidal brady-akinesia in cats].
    Bergamini L; Bonzanino O; Brignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Quattroccolo G; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1970 Feb; 91(1):62-6. PubMed ID: 5524934
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A; Bartholini G; Gey KF; Jenni A
    Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
    [No Abstract]   [Full Text] [Related]  

  • 10. L-dopa in senile dementia.
    Van Woert MH; Heninger G; Rathey U; Bowers MB
    Lancet; 1970 Mar; 1(7646):573-4. PubMed ID: 4190401
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa for progressive supranuclear palsy.
    De Renzi E; Vignolo LA
    Lancet; 1969 Dec; 2(7634):1360. PubMed ID: 4188119
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of parkinsonism with the drug L-DOPA].
    Stoliarova LG; Kistenev BA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
    [No Abstract]   [Full Text] [Related]  

  • 13. L-dopa for progressive supranuclear palsy.
    Gross M
    Lancet; 1969 Dec; 2(7634):1359-60. PubMed ID: 4188118
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacology of extrapyramidal movement disorders.
    Klawans HL
    Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
    [No Abstract]   [Full Text] [Related]  

  • 15. Similarities between neurologic effects of L-dopa and of apomorphine.
    Cotzias GC; Papavasiliou PS; Fehling C; Kaufman B; Mena I
    N Engl J Med; 1970 Jan; 282(1):31-3. PubMed ID: 4901383
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current treatment of Parkinson syndrome with L-dopa].
    Gerstendbrand F; Gründig E; Musiol A
    Pol Tyg Lek; 1972 May; 27(21):798-800. PubMed ID: 4555002
    [No Abstract]   [Full Text] [Related]  

  • 17. L-dopa and amantadine hydrochloride in extra-pyramidal disorders.
    Parkes JD; Knill-Jones RP; Clements PJ
    Postgrad Med J; 1971 Feb; 47(544):116-9. PubMed ID: 5572526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive external ophthalmoplegia with Parkinsonism and Dementia. Treatment with L-dopa. Report of an autopsied case.
    Rajput AH; Chornell G; Rozdilsky B
    Can J Ophthalmol; 1972 Jul; 7(3):368-74. PubMed ID: 5056570
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
    Hippius H; Logemann G
    Arzneimittelforschung; 1970 Jul; 20(7):894-6. PubMed ID: 5536051
    [No Abstract]   [Full Text] [Related]  

  • 20. [The therapeutic effect of L-dopa].
    Groneberg P; Struppler A
    Naturwissenschaften; 1972 Nov; 59(11):492-6. PubMed ID: 4657650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.